Ceralin Forte
Natural health product licensed in Canada
- Other names
- Ceralin
- Licence holder
- Metagenics Inc.
- NPN or DIN-HM
- 80047901
- Status
- Active licence
- Licence date
- 28 January 2014
- Revision date
- 21 November 2025
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Acide L-alpha-acétamido-bêta-mercaptopropionique Source : N-Acétyl-L-cystéine | 200 mg | Not calculated |
| Thiamine Source : Mononitrate de thiamine | 10 mg | 30,000 µg |
| Folate Source : Méthyltétrahydrofolate L-5 de calcium | 167 mcg | Not calculated |
| Vitis vinifera Source : Graine(s) Extraction ratio : 10:1 Dry plant equivalent : 680 mg Potency : 90 % Proanthocyanidins | 68 mg | Not calculated |
| Chlorhydrate d'acétyl-L-carnitine Source : N-acétyl L-chlorhydrate de carnitine | 200 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, cellulose, Dioxyde de silicium, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 3 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
A factor in the maintenance of good health. Helps the body to metabolize carbohydrates, proteins, and fats. N-acetyl-L-Cysteine is a potent antioxidant for the maintenance of good health in individuals under oxidative stress. To help relieve symptoms of chronic bronchitis. Mycolytic agent that helps relieve symptoms of chronic bronchitis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80047901
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.